PIM(R)
Commercial- Indications
- Diabetes research (islet recovery media)
Company intelligence / Profile preview
Prodo Laboratories is a specialized biotechnology company focused on the isolation and distribution of high-quality human pancreatic islets for diabetes research. The company provides a comprehensive suite of products, including its proprietary Prodo Islet Media (PIM) and primary human islet cells, to academic and pharmaceutical researchers globally. By optimizing the recovery, longevity, and functionality of islets, Prodo Labs supports critical advancements in understanding and treating Type 1 and Type 2 diabetes. In addition to product sales, the company offers contract research services for drug testing on human islet cells and islet isolation for clinical applications.
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prodo Laboratories.